The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease

Y Döring, L Pawig, C Weber, H Noels - Frontiers in physiology, 2014 - frontiersin.org
The chemokine receptor CXCR4 and its ligand CXCL12 play an important homeostatic
function by mediating the homing of progenitor cells in the bone marrow and regulating their …

SDF-1α as a therapeutic stem cell homing factor in myocardial infarction

SK Ghadge, S Mühlstedt, C Özcelik, M Bader - Pharmacology & …, 2011 - Elsevier
Myocardial infarction is associated with persistent muscle damage, scar formation and
depressed cardiac performance. Recent studies have demonstrated the clinical significance …

Stromal Cell–Derived Factor-1α Confers Protection Against Myocardial Ischemia/Reperfusion Injury: Role of the Cardiac Stromal Cell–Derived Factor-1α–CXCR4 Axis

X Hu, S Dai, WJ Wu, W Tan, X Zhu, J Mu, Y Guo… - Circulation, 2007 - Am Heart Assoc
Background—Stromal cell–derived factor-1α (SDF-1α) binding to its cognate receptor,
CXCR4, regulates a variety of cellular functions such as stem cell homing, trafficking, and …

Chemokines in vascular dysfunction and remodeling

A Schober - Arteriosclerosis, thrombosis, and vascular biology, 2008 - Am Heart Assoc
Vascular remodeling stands for structural changes of the vessel wall in response to various
noxious stimuli, which results in reorganization of the vessel wall architecture. Luminal …

A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes

R Frederich, JH Alexander, FT Fiedorek… - Postgraduate …, 2010 - Taylor & Francis
Objective: The objective was to assess the relative risk (RR) for cardiovascular (CV) events
across all 8 randomized phase 2/3 trials evaluating saxagliptin in patients with type 2 …

Chemokines in vascular remodeling

A Schober, A Zernecke - Thrombosis and haemostasis, 2007 - thieme-connect.com
The arterial vessel wall response to a variety of injuries consists in structural changes, which
can result in luminal narrowing and aggravation of the underlying disease. This arterial …

[HTML][HTML] Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium

DI Bromage, SM Davidson, DM Yellon - Pharmacology & therapeutics, 2014 - Elsevier
Alleviating myocardial injury associated with ST elevation myocardial infarction is central to
improving the global burden of coronary heart disease. The chemokine stromal cell-derived …

Crosstalk between SDF-1/CXCR4 and SDF-1/CXCR7 in cardiac stem cell migration

D Chen, Y Xia, K Zuo, Y Wang, S Zhang, D Kuang… - Scientific reports, 2015 - nature.com
Stromal cell-derived factor 1 (SDF-1) is a chemokine that can be expressed in injured
cardiomyocytes after myocardial infarction (MI). By combining with its receptor CXCR4, SDF …

Lentiviral gene transfer of SDF-1α to wounds improves diabetic wound healing

AT Badillo, S Chung, L Zhang, P Zoltick… - Journal of Surgical …, 2007 - Elsevier
BACKGROUND: Chronic wounds continue to be a major clinical problem and novel
therapeutic approaches are needed. We have previously demonstrated that treatment of …

Hypoxia inducible factor-1α, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis

MR Hoenig, C Bianchi, FW Sellke - Current drug targets, 2008 - ingentaconnect.com
Bone marrow-derived mononuclear cells differentiate into endothelial cells in adult animals,
including humans. These cells, endothelial progenitor cells (EPCs), play central roles in …